NPS PHARMACEUTICALS INC·4

Feb 18, 11:29 AM ET

NPS PHARMACEUTICALS INC 4

4 · NPS PHARMACEUTICALS INC · Filed Feb 18, 2014

Insider Transaction Report

Form 4
Period: 2014-02-13
Melrose Glenn R
SVP, Human Resources
Transactions
  • Tax Payment

    Common Stock

    2014-02-13$38.30/sh2,165$82,92026,971 total
  • Exercise/Conversion

    Common Stock

    2014-02-13+6,07529,136 total
  • Exercise/Conversion

    Restricted Stock Units

    2014-02-136,07512,151 total
    Exercise: $0.00Common Stock (6,075 underlying)
Footnotes (3)
  • [F1]Each vested Restricted Stock Unit is the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
  • [F2]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the Restricted Stock Units described in this Form 4.
  • [F3]On February 13, 2013, the Restricted Stock Units were granted with one third vesting on the first anniversary of the date of grant, one third vesting on the second anniversary of the date of grant and the remaining vesting on the third anniversary of the date of grant. As of the date of this filing, 6,075 of the Restricted Stock Units have vested.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT